dorsaVi Stock

dorsaVi ROCE

The Return on Capital Employed (ROCE) of dorsaVi (DVL.AX) as of Jul 25, 2026 is -66.34 %. In the previous year, Return on Capital Employed (ROCE) was -167.41 % — a change of -60.38% (higher).

ROCE

-66.34 %

YoY

-60.38%

Last updated:

In 2026, dorsaVi's return on capital employed (ROCE) was -66.34 %, a -60.38% increase from the -167.41 % ROCE in the previous year.

Access this data via the Eulerpool API

dorsaVi Stock analysis

What does dorsaVi do? The company dorsaVi Ltd is a leading company in the field of wearable technology based in Australia. The company was founded in 2000 by Andrew Ronchi, Andrew Dalziel, and Daniel Dorsch with the vision to improve people's health through the development of technologies that can measure human movement and performance. dorsaVi's business model is based on the development and marketing of wearable technology for use in medicine, rehabilitation, and sports. The company aims to develop innovative, user-friendly, and reliable devices that help users optimize their movement and performance. The products are used by professional athletes, physiotherapists, trainers, and doctors worldwide. dorsaVi's mission is to improve the health and well-being of people and prevent injuries by providing accurate and easy-to-use solutions. The company is built on three main pillars: Sports, Clinical, and Occupational. Each of these pillars has specific products and solutions to help users in different industries and application areas. In the Sports field, dorsaVi offers a wide range of products and solutions for professional athletes and trainers to optimize their performance and prevent injuries. The company's flagship product is the ViPerform system. This system allows athletes to accurately analyze and improve their movements during training or competition. It consists of wireless sensors attached to various parts of the body to capture data on movements, speed, acceleration, and force. The data is then sent to the dorsaVi app in real-time, where it can be analyzed, visualized, and interpreted. In the Clinical field, dorsaVi provides solutions for therapists and doctors to support patients in their recovery after an injury or surgery. The Sentral Clinical Movement Analysis System offered in this field is an advanced system for analyzing human movement. It allows therapists to observe and analyze movement patterns accurately to identify disruptions and weaknesses that may lead to pain or injuries. The collected data can help create individual therapy plans and accelerate recovery. In the Occupational field, dorsaVi develops solutions for companies and employees to improve their health and safety in the workplace. This includes the Sentral Wearable Movement Monitoring System. The system is a wireless and non-invasive solution that allows employers and employees to record and analyze their movement and load profiles in real-time. The collected data can help make ergonomic adjustments in the workplace to prevent injuries and illnesses. Over the years, dorsaVi has received numerous awards for its products and solutions. However, the company continues to strive to develop innovative technologies and products to help people optimize their movement and performance, increase their well-being, and maintain their long-term health. dorsaVi is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling dorsaVi's Return on Capital Employed (ROCE)

dorsaVi's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing dorsaVi's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

dorsaVi's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in dorsaVi’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about dorsaVi stock

Return on Capital Employed (ROCE) of dorsaVi is -66.34 % in 2026.

Access this data via the Eulerpool API

Profitability — dorsaVi

All Key Metrics — dorsaVi